Isoflurane has no effect on cognitive or behavioral performance in a mouse model of early-stage Alzheimer’s disease
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: Frontiers in Neuroscience ; 16 (2022). - Art.-Nr. 1033729.. - eISSN 1662-453X
- Keyword
-
Alzheimerkrankheit
Anästhesie
Isofluran
Kognitive Störung
- Event
-
Veröffentlichung
- (where)
-
Ulm
- (who)
-
Universität Ulm
- (when)
-
2022
- Creator
-
Borgstedt, Laura
Bratke, Sebastian
Blobner, Manfred
Pötzl, Christoph
Ulm, Bernhard
Jungwirth, Bettina
Schmid, Sebastian
- DOI
-
10.18725/OPARU-47812
- URN
-
urn:nbn:de:bsz:289-oparu-47888-6
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:48 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Borgstedt, Laura
- Bratke, Sebastian
- Blobner, Manfred
- Pötzl, Christoph
- Ulm, Bernhard
- Jungwirth, Bettina
- Schmid, Sebastian
- Universität Ulm
Time of origin
- 2022
Other Objects (12)
Automated detection of early-stage Alzheimer’s Disease
Properties of odor identification testing in screening for early-stage Alzheimer’s disease
Distinct network topology in Alzheimer’s disease and behavioral variant frontotemporal dementia
Knowledge-based compact disease models identify new molecular players contributing to early-stage Alzheimer’s disease
Amyloid antibody therapy for early-stage Alzheimer’s disease: a critical review of three recent trials
Awareness of Diagnosis in Persons with Early-Stage Alzheimer’s Disease: An Observational Study in Spain
Neuropathological and behavioral alterations in two transgenic mouse models of Alzheimer´s disease
Impact of behavioral and psychological symptoms of Alzheimer’s disease on caregiver outcomes
Reach-to-grasp kinematics and kinetics with and without visual feedback in early-stage Alzheimer’s disease
A randomized clinical trial evaluating Hydralazine’s efficacy in early-stage Alzheimer’s disease: The EHSAN Study
A Framework for the Administration of Anti-amyloid Monoclonal Antibody Treatments in Early-Stage Alzheimer’s Disease
Alzheimer’s Disease
Automated detection of early-stage Alzheimer’s Disease
Properties of odor identification testing in screening for early-stage Alzheimer’s disease
Distinct network topology in Alzheimer’s disease and behavioral variant frontotemporal dementia
Knowledge-based compact disease models identify new molecular players contributing to early-stage Alzheimer’s disease
Amyloid antibody therapy for early-stage Alzheimer’s disease: a critical review of three recent trials
Awareness of Diagnosis in Persons with Early-Stage Alzheimer’s Disease: An Observational Study in Spain
Neuropathological and behavioral alterations in two transgenic mouse models of Alzheimer´s disease
Impact of behavioral and psychological symptoms of Alzheimer’s disease on caregiver outcomes
Reach-to-grasp kinematics and kinetics with and without visual feedback in early-stage Alzheimer’s disease
A randomized clinical trial evaluating Hydralazine’s efficacy in early-stage Alzheimer’s disease: The EHSAN Study
A Framework for the Administration of Anti-amyloid Monoclonal Antibody Treatments in Early-Stage Alzheimer’s Disease
Alzheimer’s Disease
Automated detection of early-stage Alzheimer’s Disease
Properties of odor identification testing in screening for early-stage Alzheimer’s disease
Distinct network topology in Alzheimer’s disease and behavioral variant frontotemporal dementia
Knowledge-based compact disease models identify new molecular players contributing to early-stage Alzheimer’s disease
Amyloid antibody therapy for early-stage Alzheimer’s disease: a critical review of three recent trials
Awareness of Diagnosis in Persons with Early-Stage Alzheimer’s Disease: An Observational Study in Spain
Neuropathological and behavioral alterations in two transgenic mouse models of Alzheimer´s disease
Impact of behavioral and psychological symptoms of Alzheimer’s disease on caregiver outcomes
Reach-to-grasp kinematics and kinetics with and without visual feedback in early-stage Alzheimer’s disease
A randomized clinical trial evaluating Hydralazine’s efficacy in early-stage Alzheimer’s disease: The EHSAN Study
A Framework for the Administration of Anti-amyloid Monoclonal Antibody Treatments in Early-Stage Alzheimer’s Disease